Data Science Investment Counter —Funding raised by UK data science companies in 2018.
£ 5.640 Million
Loading Events

« All Events

  • This event has passed.

HealthQuake – Can AI and other frontier technologies save the health service?

February 28, 2018 @ 6:30 pm - 8:30 pm

HealthQuake – Can AI and other frontier technologies save the health service?

The ageing population, under-funding and lack of new blockbuster drugs are all putting massive pressure on global health organisations. However, artificial intelligence, advanced genomics and blockchain will help transform the future of health. Rapid developments in data science is providing the opportunity to deliver the 4Ps of health where a PREDICTIVE, PREVENTATIVE, PERSONALISED and PARTICIPATORY approach will take the pressure away from providing routine treatment and allow resources to be focused on critical care.


If you are involved in life sciences, health or insurance this event brought to you by MINDSTREAM_AI will provide major insights into what the future will bring and how to thrive as a business in this rapidly changing environment.



Dr Amy Nelson – is a Senior Research Associate at UCL Institute of Neurology and a junior doctor. She has a first class Honours degree in Pharmacology and a medical degree from University of Edinburgh, and undertook Foundation Doctor training at University College London Hospital. Her interest in machine learning prompted a career move towards medical AI with Parashkev Nachev’s group at UCL. Her current projects seek to improve the efficiency of hospital operations using AI: she has built an algorithm to predict patient non-attendance; is improving research impact measurement to better inform funding practice; and is analysing large volume cognitive data extracted from handwritten notes.

Expert panel

Rabia Khan – Rabia has a PhD in Human Genetics from McGill and an MBA. Following on from her PhD, she led the commercial arm at Meta (acquired by Chan Zuckerberg BioHub) as VP Commercial Partnerships. Meta is an artificial intelligence company that is transforming how scientific knowledge is experienced and consumed. During this role, Rabia was a key liaison between external partners to build products that leverage Meta’s knowledge graph. She was also instrumental in the Meta -IARPA partnership. Following Meta, she went on to a post-doctoral fellowship at the Francis Crick Institute, the largest biomedical research facility under a single roof in Europe. As a post-doctoral fellow, Rabia used stem cells to build biologically relevant models of the immune response to infection. She is an Exploratory Scientist at BenevolentAI, an AI – enabled drug discovery company.


Nuala Murphy – is CEO of Moment Health – a ground-breaking digital solution that offers early intervention for maternal mental health illnesses. Nuala was recently successful in receiving early stage investment to build a team and bring the first consumer and corporate offerings to market. The Irish Times describes Nuala as “rapidly developing a reputation as one of the next generation of female business leaders …”, She is a frequent participant in expert panel line-ups and avid champion of female health and equality. 2017 saw Nuala host a fireside chat with two of the most influential women in tech; Sheryl Sandberg, COO of Facebook in London and Sarah Friar CFO of Square in her home city Belfast. Nuala graduated with an honours degree in Applied Languages and Linguistics with French from the University of Manchester Institute of Science and Technology and studied at the prestigious Universite de Geneve followed by a year placement in Sanofi Aventis HQ in Paris.


Dr Philip Xiu – is the Lead Medical Officer for Medicalchain uses blockchain technology to securely store health records and maintain a single version of the truth. Different organisations such as doctors, hospitals, laboratories, pharmacists and health insurers can request permission to access a patient’s record to serve their purpose and record transactions on the distributed ledger. He is also the Editor-in-Chief of Elsevier UK’s Order Set Platform: a cloud-based solution that enables physicians, clinicians and informaticists to author, review and manage order sets in a collaborative environment, easily integrated into any hospital’s EHR/EMR. Philip is particularly interested in the application of evidence-based medicine to the digital health space, applications for blockchain technology in healthcare, and use of technology to advance diagnosis and management of diseases.


Omar Fogliadini – is Managing Director of Suisse Life Science, a biological big data analytics company, that has developed a knowledge-discovery platform to extract cause-effect relationships directly from genetic interpretation – and at scale – linking them to lifestyle data from consumer devices in real time to provide actionable recommendations. The goal is to leverage these capabilities to transform health from an expert-driven field – with poor predictive power and large gaps in its fundamental understanding of human biology – and transforming it into a data-driven predictive science that makes it as easy as possible for individuals of all ages to take a more active role in managing their health.



67-71 Shoreditch High St
London, Shoreditch E1 6JJ United Kingdom
+ Google Map
Subscribe to our newsletter